Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000516

Drug Information
SynonymsProcainamidum; BRD-K75089421-003-04-7; C13H21N3O; HMS1791J05; KBio2_006452; SMP1_000055; NCGC00024323-06; Spectrum_000836; NINDS_000931; AC1Q2ZC9; Bio1_001369; Lopac-P-9391; BSPBio_001463; BPBio1_000411; SPBio_001329; NCGC00015859-10; L001052; Prestwick0_000337; Benzamide, 4-amino-N-[2-(diethylamino)ethyl]-; KBio1_000931; NCGC00024323-03; KBioGR_000973; Novocaine amide; Prestwick3_000337; 4-14-00-01154 (Beilstein Handbook Reference); CHEMBL640; Novocainamid; Pronestyl-Sr; Novocainamide; BRD-K75089421-003-05-4; BRN 2214285; Procaine amide; CHEBI:8428; DivK1c_000931; C07401; STK367963; 614-39-1 (hydrochloride); Procainamide (INN); Benzamide, 4-amino-N-(2-(diethylamino)ethyl)- (9CI); IDI1_033933; IDI1_000931; Pronestyl; Prestwick1_000337; BSPBio_002229; Procanbid; NSC 27461; Novocamid; Procainamide [INN:BAN]; NCGC00015859-03; Benzamide, p-amino-N-(2-(diethylamino)ethyl)-; Bio2_000663; KBio3_001729; KBio3_000366; BIDD:GT0579; HSDB 3170; p-Aminobenzoic diethylaminoethylamide; Maybridge1_004389; Procapan; Procainamida; KBio2_005319; NCGC00024323-04; 4-amino-N-(2-diethylaminoethyl)benzamide; 51-06-9; KBioSS_000183; Lopac0_000995; KBio2_003884; ARONIS023727; 4-amino-N-(2-diethylaminoethyl)-benzamide; Biocoryl; Bio1_000880; NCGC00015859-02; CBDivE_003757; Bio1_000391; ST077772; Procan; Spectrum4_000487; D08421; EINECS 200-078-8; Spectrum5_000986; 2-Diethylaminoethylamid kyseliny p-aminobenzoove; 4-Amino-N-[2-(diethylamino)ethyl]benzamide; BRD-K75089421-001-02-5; 4-Amino-N-(2-(Diethylamino)Ethyl)Benzamide Sulfate; Procapan (free base); LS-25492; WLN: ZR DVM2N2&2; MolPort-001-783-481; DB01035; UNII-L39WTC366D; PROCAINAMIDE; KBio3_000365; AC1L1J8A; 2-Diethylaminoethylamid kyseliny p-aminobenzoove [Czech]; KBioGR_000183; HMS2089E13; CAS-614-39-1; NSC27461; NCGC00024323-05; AC1Q2ZCA; 4-Amino-N-(2-(diethylamino)ethyl)benzamide; NCGC00015859-01; Spectrum2_001295; SPBio_002294; Procamide; Bio2_000183; KBio2_002751; AKOS000271131; Benzamide, p-amino-N-[2-(diethylamino)ethyl]-; HMS553P13; CID4913; HMS1361J05; Prestwick2_000337; AC1Q2ZC8; Procainamidum [INN-Latin]; HMS1989J05; KBio2_000183; BSPBio_000373; Procainamida [INN-Spanish]; Benzamide, 4-amino-N-(2-(diethylamino)ethyl)-; KBioSS_001316; Spectrum3_000555; AB00053530; KBio2_001316; p-Amino-N-(2-diethylaminoethyl)benzamide
Trade NamePronestyl; Procan; Procanbid
IndicationVentricular arrhythmias
[ICD9: 427.1   ICD10: I47.2]
Approved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESCCN(CC)CCNC(=O)C1=CC=C(C=C1)N    
Therapeutic ClassAnti-Arrhythmia Agents
CAS NumberCAS 51-06-9
PubChem Compound IDCID 4913.
PubChem Substance IDSID 9605.
SuperDrug ATC IDC01BA02
SuperDrug CAS ID000051069;
TargetSodium channel protein type 5 subunit alphaBlocker[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 089257 To Reference
Ref 2Isolated perfused and paced guinea pig heart to test for drug-induced changes of the QT interval. J Pharmacol Toxicol Methods. 2006 Nov-Dec;54(3):278-87. Epub 2006 Feb 28. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543